Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125868431 | 12586843 | 1 | I | 20160720 | 20160725 | 20160725 | PER | US-PFIZER INC-2016354669 | PFIZER | 0.00 | Y | 0.00000 | 20160725 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125868431 | 12586843 | 1 | PS | ESTRING | ESTRADIOL | 1 | U | 20472 | VAGINAL DELIVERY SYSTEM | ||||||||||
| 125868431 | 12586843 | 2 | SS | TESTOSTERONE. | TESTOSTERONE | 1 | U | 0 | CREAM | ||||||||||
| 125868431 | 12586843 | 3 | SS | MINIVELLE | ESTRADIOL | 1 | U | 0 | TRANSDERMAL PATCH | ||||||||||
| 125868431 | 12586843 | 4 | SS | PROGESTERONE. | PROGESTERONE | 1 | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125868431 | 12586843 | 2 | Hormone level abnormal |
| 125868431 | 12586843 | 3 | Hormone level abnormal |
| 125868431 | 12586843 | 4 | Hormone level abnormal |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125868431 | 12586843 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125868431 | 12586843 | Uterine haemorrhage |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |